University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 5 of 23
Visual Attention to Text and Pictorial Food Labels: An Eye Tracking Experiment
NCT05958888
Practice Experiences for School Reintegration
NCT05934396
Improving Providers' Decision-Making and Reducing Information Overload Using Information Visualization in EHRs
NCT05937646
Impact of a Telenovela/Soap Opera for HIV Prevention in Latinas
NCT05929482
Brain Network Dynamics of Depression During Esketamine Treatment
NCT06012916
Preoperative Maximum Inspiratory Pressure and Outcomes After Interscalene Block in Obese Patients
NCT06549244
Effects of Gamma-tACS on Memory and Sleep
NCT05907707
Testing "Ultraprocessed" Front-of-package Label Among Brazilian Consumers
NCT05842460
Testing Product Messages in Colombia
NCT05783726
Brief Intervention to Prevent Alcohol Socialization (BIPAS Alcohol)
NCT05520333
Study for IFE4PrEP Intervention on PrEP Uptake by Southern African American Women
NCT05087927
Pilot Mobile Medical Unit Study for I'm Fully Empowered4Her
NCT05644834
Immune Mechanisms of Vitamin D to Reduce Chronic Pain After Burn
NCT05619289
Feasibility of a Train-the-Trainer Delivered Exercise Intervention in Firefighters
NCT05287594
Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis
NCT05740618
Improving the Outcomes of Adolescents With ADHD Via a Pre-visit Question Prompt List/Video Intervention
NCT05835362
Augmenting Single-session Behavioral Activation (BA) With Delta-beta Transcranial Alternating Current Stimulation (tACS) for the Treatment of Depression
NCT05693922
Vitamin D to ENhance TraUma REcovery
NCT05458024
Effects of 'Pinkwashed' Alcohol Ads in an Online RCT
NCT05700019
Causal Role of Frontostriatal Circuitry in Goal-directed Behavior
NCT05593965
Knowledge of Nutritional Concerns in Physically Active Females
NCT05589077
Genetic Architecture of Avoidant/Restrictive Food Intake Disorder
NCT05605067
Effects of Characters on Parents' Perceptions of Breakfast Cereals
NCT05639335
Comparison of Clinical Outcomes Between GentleWave® and Biolase®
NCT05555043
Internal Jugular Vein Compression Collar for Novel Symptomatic Treatment of Venous Pulsatile Tinnitus
NCT05441540
Body and Social Behavior
NCT05654441
Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART
NCT05604209
Evaluation of a Carbon Nanotube Enabled Solid-State Head CT
NCT04495634
Effects of Semaglutide on Nicotine Intake
NCT05530577
Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)
NCT04901455
The BEST Trial: Biomarkers for Evaluating Spine Treatments
NCT05396014
Brain and Stress Study
NCT06044090
Semaglutide for Alcohol Use Disorder
NCT05520775
Written Exposure Therapy to Improve Lives After Stress Exposure
NCT05390775
Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression
NCT05543746
Understanding Changes in Physical Function Using Principles of Precision Medicine
NCT05581082
Diagnostic Accuracy of a Novel Machine Learning Algorithm to Estimate Gestational Age
NCT05433519
Mindfulness Intervention in Young Adults With a Concussion History
NCT05399849
Estrogen Variability and Irritability During the Menopause Transition
NCT05388656
Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women
NCT04900974
The Impact of Real-World Vibration Feedback Gait Retraining on Gait Biomechanics in People With Chronic Ankle Instability
NCT05327244
OA Clinic-Community CARE Model
NCT05349500
Variation In Facial Morphology As A Determinant Of Face Covering Performance: FACEFIT
NCT05388201
Effects of Curcumin-containing Toothpaste on Dental Biofilm and Associated Oral Halitosis
NCT04998617
Ulipristal Acetate for Use in Early Pregnancy Loss
NCT05216952
Love Infection: A Dramatized Story Intervention (Telenovela/Soap Opera) for HIV Prevention
NCT05358366
Adaptive Goals and Interventions for Lifestyle Enhancement
NCT04922216
Wet-to-dry vs Petrolatum & Non-stick Dressings After Hidradenitis Suppurativa Surgery
NCT05194969
Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae
NCT05294588
Examining the Impacts of Fidget Technology on Attention in Children With ADHD
NCT05384717
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.